ARCHIVES

NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial.

This article is from The Cancer Letter archive.

Vol. 33 No. 15 | April 20, 2007

Download PDF Visit The Full Archive

Related Articles

DCBD Board Rejects Breast Cancer Multiple Markers Concept Proposal

November 4, 1983

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

August 26, 2005

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

November 10, 1995

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

In Brief: Von Hoff to Direct Arizona Cancer Center; American Health Foundation Appoints Nixon

April 23, 1999

DRCA Planning Described; New Cancer Control Conference Set

February 4, 1983